These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 21508005

  • 1. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.
    Hammerstingl C, Omran H.
    Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005
    [Abstract] [Full Text] [Related]

  • 2. Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive procedures.
    Hammerstingl C, Omran H, Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events.
    Thromb Haemost; 2009 Jun; 101(6):1085-90. PubMed ID: 19492151
    [Abstract] [Full Text] [Related]

  • 3. Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry.
    Hammerstingl C, Schmitz A, Fimmers R, Omran H.
    Cardiovasc Ther; 2009 Jun; 27(4):230-8. PubMed ID: 19903186
    [Abstract] [Full Text] [Related]

  • 4. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
    Omran H, Bauersachs R, Rübenacker S, Goss F, Hammerstingl C.
    Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
    [Abstract] [Full Text] [Related]

  • 5. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
    Omran H, Hammerstingl C, Paar WD, Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events.
    Med Klin (Munich); 2007 Oct 15; 102(10):809-15. PubMed ID: 17928964
    [Abstract] [Full Text] [Related]

  • 6. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S, Barbano B, Cianci R, Gigante A, Di Donato D, Asllanaj B, Dimko M, Mariotti A, Morabito S, Pugliese F.
    G Ital Nefrol; 2010 Oct 15; 27(6):649-54. PubMed ID: 21132647
    [Abstract] [Full Text] [Related]

  • 7. Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry.
    Hammerstingl C, Tripp C, Schmidt H, von der Recke G, Omran H.
    J Heart Valve Dis; 2007 May 15; 16(3):285-92. PubMed ID: 17578050
    [Abstract] [Full Text] [Related]

  • 8. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred?
    Weiss A, Brose S, Ploetze K, Matschke K.
    Clin Hemorheol Microcirc; 2013 Jan 01; 54(3):249-58. PubMed ID: 23648452
    [Abstract] [Full Text] [Related]

  • 9. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT, Krisnaswami A, Le CU, Chan J, Shenoy BN.
    Am J Cardiol; 2009 Nov 15; 104(10):1429-33. PubMed ID: 19892063
    [Abstract] [Full Text] [Related]

  • 10. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
    Pengo V, Cucchini U, Denas G, Erba N, Guazzaloca G, La Rosa L, De Micheli V, Testa S, Frontoni R, Prisco D, Nante G, Iliceto S, Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic Therapies (FCSA).
    Circulation; 2009 Jun 09; 119(22):2920-7. PubMed ID: 19470892
    [Abstract] [Full Text] [Related]

  • 11. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V, Bail DH, Graf D, Walker T, Rittig K, Ziemer G.
    J Heart Valve Dis; 2008 May 09; 17(3):335-42. PubMed ID: 18592932
    [Abstract] [Full Text] [Related]

  • 12. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
    Saccullo G, Malato A, Raso S, Santoro M, Zammit V, Casuccio A, Siragusa S.
    Am J Hematol; 2012 Apr 09; 87(4):388-91. PubMed ID: 22374861
    [Abstract] [Full Text] [Related]

  • 13. How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study.
    Hammerstingl C, Omran H, Tripp C, Poetzsch B.
    Thromb Haemost; 2009 Feb 09; 101(2):325-32. PubMed ID: 19190817
    [Abstract] [Full Text] [Related]

  • 14. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F, Pignatelli P, Malato A, Poli D, Di Minno MN, Di Gennaro L, Rancan E, Pastori D, Grifoni E, Squizzato A, Siragusa S, Di Minno G, Ageno W.
    Am J Hematol; 2012 Apr 09; 87(4):384-7. PubMed ID: 22367852
    [Abstract] [Full Text] [Related]

  • 15. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD, Johnson JA, Turpie AG.
    Arch Intern Med; 2004 Jun 28; 164(12):1319-26. PubMed ID: 15226166
    [Abstract] [Full Text] [Related]

  • 16. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004 Jun 28; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C, Nixdorff U, Hofmann T, Lehmacher W, Daniel WG, Hanrath P, Geller C, Mügge A, Sehnert W, Schmidt-Lucke C, Schmidt-Lucke JA, ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group.
    Circulation; 2004 Mar 02; 109(8):997-1003. PubMed ID: 14967716
    [Abstract] [Full Text] [Related]

  • 18. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM, Marín F, Hurtado JA, Valencia J, Pinar E, Pineda J, Gimeno JR, Sogorb F, Valdés M, Lip GY.
    J Am Coll Cardiol; 2008 Feb 26; 51(8):818-25. PubMed ID: 18294566
    [Abstract] [Full Text] [Related]

  • 19. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
    Du L, Zhang Y, Wang W, Hou Y.
    Pacing Clin Electrophysiol; 2014 Nov 26; 37(11):1573-86. PubMed ID: 25234639
    [Abstract] [Full Text] [Related]

  • 20. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
    Daniels PR, McBane RD, Litin SC, Ward SA, Hodge DO, Dowling NF, Heit JA.
    Thromb Res; 2009 Jul 26; 124(3):300-5. PubMed ID: 19232682
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.